The clinical analysis service of Almansa Integrated Care Management, dependent on the Castilla-La Mancha Health Service (SESCAM), has taken over during the first quarter of the year. 44 New techniques reduce analytical referral to outside laboratories.
This increase in the service portfolio is the result of the development of new regional competition in this area, through which the Almansa laboratory now has new analysis techniques such as immunochemistry, capillary electrophoresis and flow cytometry which They allow several tests to be performed such as biological and tumor markers, hormones and vitamins, diabetes control markers or proteinograms before being sent to the reference hospital.
With 44 new technologies, the laboratory has gone on to complete 154 technologies in the areas of clinical analysis and hematology, including 288,783 analytical tests during the first quarter of this year, reaching 94 percent of reported analytical tests. went. “This 94 per cent implies a high level of commitment on the part of the service, A percentage that, during the last year, before the catalog change, was around 84 percent”, explained Regina Leal, Managing Director of ESCAM.
In 2022, 1,273,233 tests of 90,828 analytical requests were reported, both in routine primary and hospital care and urgent care, of which 83.7 percent were performed in the laboratory with the 110 implantable technologies that have demonstrated their fundamental role in clinical assistance. Gives an idea of the role. Almansa Management.
In addition to advances in diagnostic techniques, Greater security and speed in getting results is achieved, something in which the technological innovation that is required is important. Efforts have been made to enhance the automation of laboratory preanalytics. The system allows for automated dispensing, decapping, aliquoting, capping and collection of patient samples, which will result in greater safety for laboratory staff and patients.
Another advantage of the new equipment is that Any tube can be immediately included in the equipment and primed for immediate analysis, without waiting to be processed, significantly reducing wait times in services such as the emergency department.
Integrated into a system of biochemical analytical equipment full automation, This allows for increased sample traceability and optimization of workflow thanks to the fact that manipulation of the samples is reduced.
Finally, the Central Laboratory’s new analytical system does not consume water (dry chemistry instead of liquid chemistry), a system that offers great speed and reliability, as well as cost savings, as well as a fair use of this previously precious Assets contribute to management. Further certification of the Environmental Management System of this Management in accordance with the ISO 14001 standard.
